March 9, 2006 (San Francisco) — The largest and arguably most complex risk-management program ever undertaken by the US Food and Drug Administration is sparking a commensurate measure of controversy — ...

In December 2021, major changes took effect in the iPLEDGE program, the US Food and Drug Administration (FDA)–required safety program for managing the risks of isotretinoin's teratogenicity and ...

Add Yahoo as a preferred source to see more of our stories on Google. Q: I’m dealing with hormonal acne. What’s the best way to clear it up?. “I’m a big fan of topical probiotics for hormonal ...

Please provide your email address to receive an email when new articles are posted on . iPLEDGE requires participating pharmacies to have an identifying number, which jails and prisons do not have.

Please provide your email address to receive an email when new articles are posted on . Pregnancies, abortions and fetal defects associated with isotretinoin exposure continue to be a problem even ...

Dermatologists have complained that the U.S. Food and Drug Administration's iPledge program is delaying treatment for patients who require the drug Accutane. The program, which was adapted six months ...

It has been 13 years since the U.S. Food and Drug Administration took a bold step to prevent birth defects caused by the only drug that can cure severe acne. Women were still getting pregnant while ...

Jessica Soohoo, a 20-year-old student in New Jersey, was supposed to start her sixth and final month of isotretinoin acne treatment in December. Isotretinoin is the generic name for Absorica, Claravis ...

More than 120 pregnancies were exposed to a birth defect-causing agent during the first year of iPledge, a mandatory program designed to prevent pregnant women from being exposed to the anti-acne ...

WASHINGTON The Food and Drug Administration announced that Covance, the developer of the iPLEDGE risk management program has fully implemented the program revisions approved by the FDA on Oct. 3. The ...

(National-NBC) February 24, 2006 - A new program to prevent pregnant women from taking the acne drug Accutane is set to start next Wednesday. The program, called ...